Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Mineralys Therapeutics Inc

MLYS
10,24
0,04 (0,39%)
15 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/2/202512:03EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/2/202513:07EDGAR2Form 8-K - Current report
12/2/202513:00GLOBEMineralys Therapeutics Reports Fourth Quarter and Full Year..
05/2/202522:05GLOBEMineralys Therapeutics to Announce Fourth Quarter and Full..
04/2/202514:05EDGAR2Form 8-K - Current report
04/2/202514:00GLOBEMineralys Therapeutics Completes Enrollment in Explore-CKD..
08/1/202514:07EDGAR2Form 8-K - Current report
08/1/202514:00GLOBEMineralys Therapeutics Announces Phase 2 Clinical Trial of..
13/11/202422:27EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202422:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/11/202414:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202414:32EDGAR2Form 8-K - Current report
11/11/202422:05GLOBEMineralys Therapeutics Reports Third Quarter 2024 Financial..
05/11/202422:05GLOBEMineralys Therapeutics to Participate in Upcoming Investor..
30/10/202413:03EDGAR2Form 8-K - Current report
30/10/202413:00GLOBEMineralys Therapeutics Completes Enrollment Ahead of..
22/10/202414:00GLOBEMineralys to Host Virtual KOL Event on the Unmet Medical..
25/9/202414:06EDGAR2Form 8-K - Current report
25/9/202414:00GLOBEMineralys Therapeutics Completes Target Enrollment in..
13/8/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202422:07EDGAR2Form 8-K - Current report
13/8/202422:05GLOBEMineralys Therapeutics Reports Second Quarter 2024 Financial..
05/8/202422:05GLOBEMineralys Therapeutics to Announce Second Quarter 2024..
17/6/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/6/202414:06EDGAR2Form 8-K - Current report
14/6/202414:00GLOBEMineralys Therapeutics Appoints Biopharmaceutical Executive..
10/6/202422:02EDGAR2Form 8-K - Current report
31/5/202422:06EDGAR2Form 8-K - Current report
23/5/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:38EDGAR2Form 8-K - Current report
09/5/202413:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:07EDGAR2Form 8-K - Current report
09/5/202413:00GLOBEMineralys Therapeutics Reports First Quarter 2024 Financial..
06/5/202414:00GLOBEMineralys Therapeutics to Participate in the Bank of America..
02/5/202414:00GLOBEMineralys Therapeutics to Announce First Quarter 2024..
21/3/202412:00GLOBEMineralys Therapeutics Reports Fourth Quarter and Full Year..
13/3/202421:05GLOBEMineralys Therapeutics to Announce Fourth Quarter and Full..
Apertura: 10,15 Min: 10,08 Max: 10,6405
Chiusura: 10,20

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network